Shockley M S, Burford N T, Sadée W, Lameh J
Department of Biopharmaceutical Sciences, University of California at San Francisco 94143-0446, USA.
J Neurochem. 1997 Feb;68(2):601-9. doi: 10.1046/j.1471-4159.1997.68020601.x.
Human m1 muscarinic acetylcholine receptor mutants were screened to determine receptor domains and cellular pathways relevant to down-regulation. Mutations in the second intracellular loop and the junctions of the third intracellular loop of the receptor, where a role for receptor activation or internalization had been previously demonstrated in HEK293 cells, were selected for this study. To assess receptor down-regulation, the m1 receptor mutants were transfected into Chinese hamster ovary cells. Because receptor internalization is expected to precede down-regulation, mutants displaying intact internalization were selected to permit interpretation of mutational effects on down-regulation alone. Four mutations were identified that specifically impaired down-regulation without altering receptor internalization: V127A, I211A, E360A, and K362A. The results define new receptor domains in the second intracellular loop and the junctions of the third intracellular loop that are involved in down-regulation. These same four mutants were also defective in signaling via the phospholipase C and the adenylyl cyclase pathways and in G protein activation, as measured by [35S]GTP gamma S binding. However, the level of second messenger stimulation correlated poorly with the extent of down-regulation. In summary, several mutations of the m1 receptor selectively affect down-regulation, demonstrating that internalization and down-regulation represent distinct events driven by different cellular mechanisms.
对人毒蕈碱型乙酰胆碱M1受体突变体进行筛选,以确定与下调相关的受体结构域和细胞途径。本研究选择了受体第二内环和第三内环连接处的突变,此前已在HEK293细胞中证明这些区域在受体激活或内化中发挥作用。为了评估受体下调情况,将M1受体突变体转染到中国仓鼠卵巢细胞中。由于预期受体内化先于下调,因此选择显示完整内化的突变体,以便仅解释突变对下调的影响。鉴定出四个特异性损害下调而不改变受体内化的突变:V127A、I211A、E360A和K362A。结果确定了第二内环和第三内环连接处参与下调的新受体结构域。通过[35S]GTPγS结合测量,这四个相同的突变体在通过磷脂酶C和腺苷酸环化酶途径的信号传导以及G蛋白激活方面也存在缺陷。然而,第二信使刺激水平与下调程度的相关性较差。总之,M1受体的几个突变选择性地影响下调,表明内化和下调是由不同细胞机制驱动的不同事件。